Quick Answer
TENAX THERAPEUTICS, INC. reported Net Income of -$52.60 million for fiscal year 2025.
TENAX THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$52.60M | -198.8% |
| 2024 | -$17.60M | -128.3% |
| 2023 | -$7.71M | -169.8% |
| 2022 | $11.05M | +134.0% |
| 2021 | -$32.47M | -229.6% |
| 2020 | -$9.85M | -17.4% |
| 2019 | -$8.39M | +40.7% |
| 2018 | -$14.14M | -60.0% |
| 2017 | -$8.84M | +79.9% |
| 2016 | -$43.92M | -211.9% |
| 2015 | -$14.08M | +27.9% |
| 2014 | -$19.54M | -107.5% |
| 2013 | -$9.42M | +40.1% |
| 2012 | -$15.71M | -250.4% |
| 2011 | $10.45M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.80M | -299.0% | -45.7% |
| June 30, 2025 | -$10.85M | -203.4% | -4.2% |
| March 31, 2025 | -$10.41M | -174.0% | -162.8% |
| September 30, 2024 | -$3.96M | -300.9% | -10.8% |
| June 30, 2024 | -$3.58M | -223.1% | +5.9% |
| March 31, 2024 | -$3.80M | -170.1% | -292.6% |
| September 30, 2023 | $1.97M | -32.4% | +278.2% |
| June 30, 2023 | -$1.11M | +61.3% | +21.4% |
- TENAX THERAPEUTICS, INC. showed a decrease of -198.8% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, TENAX THERAPEUTICS, INC.’s net income has declined by 603.4% (from $10.45 million to -$52.60 million).
- The most recent figure is from TENAX THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: